SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
REPL

Replimune Group, Inc. (NASDAQ:REPL)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
12.33+0.87 (+7.55%)
 
Market cap
$1.16B
Analyst consensus
Listed since
Jul 20, 2018
Insider Score
––Not scored
REPL Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

REPL Top Shareholders

ShareholderShares Held
Scanning latest 13F filings…

REPL Options Owners

ShareholderSecurityUnderlying Shares
No option positions on REPL in recent 13F filings.

Source: SEC EDGAR Form 13F filings.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.